BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25707769)

  • 1. GATA2 promotes glioma progression through EGFR/ERK/Elk-1 pathway.
    Wang Z; Yuan H; Sun C; Xu L; Chen Y; Zhu Q; Zhao H; Huang Q; Dong J; Lan Q
    Med Oncol; 2015 Apr; 32(4):87. PubMed ID: 25707769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PTPN1 promotes the progression of glioma by activating the MAPK/ERK and PI3K/AKT pathways and is associated with poor patient survival.
    Jin T; Li D; Yang T; Liu F; Kong J; Zhou Y
    Oncol Rep; 2019 Aug; 42(2):717-725. PubMed ID: 31173266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation.
    Ding Z; Liu X; Liu Y; Zhang J; Huang X; Yang X; Yao L; Cui G; Wang D
    Mol Carcinog; 2015 May; 54(5):405-15. PubMed ID: 24347226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Expression of TGFBI Promotes the Proliferation and Migration of Glioma Cells.
    Guo SK; Shen MF; Yao HW; Liu YS
    Cell Physiol Biochem; 2018; 49(3):1097-1109. PubMed ID: 30196284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells.
    Das G; Shiras A; Shanmuganandam K; Shastry P
    Mol Carcinog; 2011 Jun; 50(6):412-23. PubMed ID: 21557327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of TIP30 inhibits the growth and invasion of glioma cells.
    Hu Y; Chen F; Liu F; Liu X; Huang N; Cai X; Sun Y; Li A; Luo R
    Mol Med Rep; 2016 Jan; 13(1):605-12. PubMed ID: 26718891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PJ-34 inhibits PARP-1 expression and ERK phosphorylation in glioma-conditioned brain microvascular endothelial cells.
    Motta C; D'Angeli F; Scalia M; Satriano C; Barbagallo D; Naletova I; Anfuso CD; Lupo G; Spina-Purrello V
    Eur J Pharmacol; 2015 Aug; 761():55-64. PubMed ID: 25934569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibulin-5 is a prognostic marker that contributes to proliferation and invasion of human glioma cells.
    Sheng XD; Chen H; Wang H; Ding ZB; Xu GZ; Zhang JF; Lu WC; Wu T; Zhao L
    Asian Pac J Cancer Prev; 2015; 16(2):769-73. PubMed ID: 25684523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
    Mut M; Lule S; Demir O; Kurnaz IA; Vural I
    Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA interference targeting NRP-1 inhibits human glioma cell proliferation and enhances cell apoptosis.
    Li X; Tang T; Lu X; Zhou H; Huang Y
    Mol Med Rep; 2011; 4(6):1261-6. PubMed ID: 21842123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference against TMEM97 inhibits cell proliferation, migration, and invasion in glioma cells.
    Qiu G; Sun W; Zou Y; Cai Z; Wang P; Lin X; Huang J; Jiang L; Ding X; Hu G
    Tumour Biol; 2015 Sep; 36(10):8231-8. PubMed ID: 26002575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gab2 expression in glioma and its implications for tumor invasion.
    Shi L; Sun X; Zhang J; Zhao C; Li H; Liu Z; Fang C; Wang X; Zhao C; Zhang X; Zhou F; Lu S; Luo R; Zhang B
    Acta Oncol; 2013 Nov; 52(8):1739-50. PubMed ID: 23231021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms underlying effects of epidermal growth factor receptor inhibition on invasion, proliferation, and angiogenesis in experimental glioma.
    Guillamo JS; de Boüard S; Valable S; Marteau L; Leuraud P; Marie Y; Poupon MF; Parienti JJ; Raymond E; Peschanski M
    Clin Cancer Res; 2009 Jun; 15(11):3697-704. PubMed ID: 19435839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of PDGFR by imatinib elicits the sustained activation of ERK and downstream receptor signaling in malignant glioma cells.
    Dong Y; Jia L; Wang X; Tan X; Xu J; Deng Z; Jiang T; Rainov NG; Li B; Ren H
    Int J Oncol; 2011 Feb; 38(2):555-69. PubMed ID: 21152856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protein kinase C-eta isoform induces proliferation in glioblastoma cell lines through an ERK/Elk-1 pathway.
    Uht RM; Amos S; Martin PM; Riggan AE; Hussaini IM
    Oncogene; 2007 May; 26(20):2885-93. PubMed ID: 17146445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorigenesis and prognostic role of hepatoma-derived growth factor in human gliomas.
    Hsu SS; Chen CH; Liu GS; Tai MH; Wang JS; Wu JC; Kung ML; Chan EC; Liu LF
    J Neurooncol; 2012 Mar; 107(1):101-9. PubMed ID: 22037800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T11TS inhibits Angiopoietin-1/Tie-2 signaling, EGFR activation and Raf/MEK/ERK pathway in brain endothelial cells restraining angiogenesis in glioma model.
    Bhattacharya D; Chaudhuri S; Singh MK; Chaudhuri S
    Exp Mol Pathol; 2015 Jun; 98(3):455-66. PubMed ID: 25797371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro study on the suppressive effect of glioma cell growth induced by plasmid-based small interference RNA (siRNA) targeting human epidermal growth factor receptor.
    Kang CS; Pu PY; Li YH; Zhang ZY; Qiu MZ; Huang Q; Wang GX
    J Neurooncol; 2005 Sep; 74(3):267-73. PubMed ID: 16132520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-suppressive function of long noncoding RNA MALAT1 in glioma cells by downregulation of MMP2 and inactivation of ERK/MAPK signaling.
    Han Y; Wu Z; Wu T; Huang Y; Cheng Z; Li X; Sun T; Xie X; Zhou Y; Du Z
    Cell Death Dis; 2016 Mar; 7(3):e2123. PubMed ID: 26938295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.
    Ito T; Yamada S; Tanaka C; Ito S; Murai T; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.